Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Med Chem Lett ; 10(11): 1568-1572, 2019 Nov 14.
Article in English | MEDLINE | ID: mdl-31749912

ABSTRACT

Carfentanil is a synthetic opioid significantly more potent than clinically prescribed fentanyl. The primary metabolites of carfentanil, generated from human liver microsomes, were structurally confirmed through chemical synthesis. The synthesized compounds were evaluated for µ-opioid receptor (MOR) functional activity. Of the six metabolites assayed, a major metabolite showed comparable activity to the parent opioid. Three other metabolites showed significant MOR functional activity. The availability of the metabolites could aid improvements in the analysis of biomedical samples obtained from suspected human exposures to carfentanil and development of treatment protocols.

2.
Article in English | MEDLINE | ID: mdl-23624235

ABSTRACT

The analysis of biomedical samples such as urine and blood can provide evidence of exposure to chemicals for a range of applications including occupational exposure monitoring, detection of drugs of abuse, performance enhancement in sport and investigations of poisoning and incapacitation. This paper reports the development of an analytical method for two suspected urinary metabolites of the riot control agent 2-chlorobenzylidene malononitrile (CS): 2-chlorohippuric acid and 2-chlorobenzyl-N-acetylcysteine. 2-Chlorohippuric acid was identified in all 2h post-exposure samples from a set of urine samples taken from army recruits exposed to low levels of thermally dispersed CS during training. 2-Chlorobenzyl-N-acetylcysteine, a metabolite known to be formed in the rat, was not identified in any of the samples. The lower limit of detection (LLOD) for 2-chlorohippuric acid and 2-chlorobenzyl-N-acetylcysteine was 1ng/ml and 0.5ng/ml in pooled urine from the pre-exposed subjects. 2-Chlorohippuric acid was rapidly excreted but was detectable in the urine of 17 of the 19 subjects tested 20h after exposure.


Subject(s)
Chromatography, Liquid/methods , Hippurates/urine , Riot Control Agents, Chemical/metabolism , Riot Control Agents, Chemical/urine , Tandem Mass Spectrometry/methods , o-Chlorobenzylidenemalonitrile/metabolism , o-Chlorobenzylidenemalonitrile/urine , Adolescent , Adult , Animals , Humans , Limit of Detection , Male , Rats , Riot Control Agents, Chemical/administration & dosage , Young Adult , o-Chlorobenzylidenemalonitrile/administration & dosage
3.
Int J Antimicrob Agents ; 41(6): 552-7, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23517714

ABSTRACT

Burkholderia pseudomallei is the causative agent of the disease melioidosis, which is prevalent in tropical countries and is intractable to a number of antibiotics. In this study, the antibiotic co-trimoxazole (trimethoprim/sulfamethoxazole) was assessed for the post-exposure prophylaxis of experimental infection in mice with B. pseudomallei and its close phylogenetic relative Burkholderia mallei, the causative agent of glanders. Co-trimoxazole was effective against an inhalational infection with B. pseudomallei or B. mallei. However, oral co-trimoxazole delivered twice daily did not eradicate infection when administered from 6h post exposure for 14 days or 21 days, since infected and antibiotic-treated mice succumbed to infection following relapse or immunosuppression. These data highlight the utility of co-trimoxazole for prophylaxis both of B. pseudomallei and B. mallei and the need for new approaches for the treatment of persistent bacterial infection.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Chemoprevention/methods , Glanders/prevention & control , Inhalation Exposure/prevention & control , Melioidosis/prevention & control , Post-Exposure Prophylaxis/methods , Trimethoprim, Sulfamethoxazole Drug Combination/administration & dosage , Administration, Oral , Animals , Burkholderia mallei/drug effects , Burkholderia pseudomallei/drug effects , Disease Models, Animal , Female , Mice , Mice, Inbred BALB C , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...